AbL Diagnostics SA (ABLD) — Capital Reinvestment Ratio
AbL Diagnostics SA (ABLD) has a Capital Reinvestment Ratio of 0.84x as of June 2025, meaning it reinvests 1% of its operating cash flow (€479.46K) in capital expenditures (€400.39K). See net asset quality index of AbL Diagnostics SA to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
AbL Diagnostics SA Capital Reinvestment Ratio (2017–2023)
This chart tracks AbL Diagnostics SA's Capital Reinvestment Ratio across 3 annual periods. Check AbL Diagnostics SA total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for AbL Diagnostics SA (2017–2023)
Year-by-year Capital Reinvestment Ratio for AbL Diagnostics SA from 2017 to 2023. For live market cap and broader valuation context, see ABLD company net worth.
| Year | Reinvestment Ratio | Operating CF (EUR) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2023 | 1.01x | €926.43K | €938.50K | ▼ -87.3% |
| 2018 | 7.95x | €81.10K | €644.40K | ▲ +1658.8% |
| 2017 | 0.45x | €675.20K | €305.02K | — |